Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, January 2000, p. 9-13, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Opsonization and Phagocytosis of Plasmodium
falciparum Merozoites Measured by Flow Cytometry
Lakshmi M.
Kumaratilake1,* and
Antonio
Ferrante1,2
Department of
Immunopathology1 and University of
Adelaide Department of Paediatrics,2
Women's and Children's Hospital, Adelaide, South Australia 5006, Australia
Received 10 May 1999/Returned for modification 9 August
1999/Accepted 16 September 1999
 |
ABSTRACT |
A flow cytometric phagocytosis assay was established to investigate
the role of anti-merozoite antibody, complement, and cytokines on the
phagocytosis of Plasmodium falciparum merozoites by human neutrophils. This assay involved allowing fluorescein
isothiocyanate-labeled merozoites to interact with phagocytes and
analysis of the cells on a FACScan with Lysis II software. To
differentiate the proportion of neutrophil surface-bound merozoites
from the merozoites ingested by neutrophils, the fluorescence of bound
merozoites was quenched by adding trypan blue. The data showed that
sera from malaria-immune individuals in the Solomon Islands and Papua
New Guinea promoted merozoite engulfment by neutrophils. The cytokines
tumor necrosis factor alpha, gamma interferon, granulocyte-macrophage
colony-stimulating factor, and interleukin-1
significantly
increased the amount and the rate of merozoite phagocytosis by
neutrophils. Optimum merozoite phagocytosis occurred when both
cytokines and anti-malarial antibody were present.
 |
INTRODUCTION |
Immune responses to the merozoite
stage are important in resistance to malaria, since this transitory
stage, which emerges from schizonts, is responsible for the initiation
and perpetuation of both the asexual and sexual parasite life cycles in
the host's blood. Vaccine strategies aim to direct the immune response
against merozoites (3, 4, 10, 11), since antibodies to
merozoite surface proteins have been shown to block adhesion and
invasion of host erythrocytes (RBC) (1, 5, 8, 22, 27).
However, vaccine strategies need to take into consideration not only
the merozoite invasion inhibition activity of the antibody but also its
ability to promote phagocytosis of merozoites. Phagocytosis of
Plasmodium falciparum merozoites has been observed in
infected individuals (29, 31). Rapid phagocytosis not only
prevents merozoite invasion of RBC but also reduces toxic effects known to be caused by the membrane anchor molecules of merozoite surface proteins (9, 25).
Studies of merozoite phagocytosis have been hampered for several
reasons. The studies carried out on human monocytes (2, 13,
14) and neutrophils (19) depended on light-microscopic observations. Morphology-based microscopic examination of merozoites (size, 1.0 to 1.2 µm) is tedious, subjective, and time-consuming. Studies which used purified merozoites are rare, and in fact, mature
schizonts have been commonly used as a source of merozoites (1, 4,
8, 27).
We have now developed a nonsubjective and versatile method for
measuring phagocytosis of P. falciparum merozoites by human neutrophils by flow cytometric analysis. Purified merozoites were used
to ensure that merozoite-specific immune mechanisms could be studied.
Using this system, we have reexamined and extended the known immune
factors which influence phagocytosis of P. falciparum merozoites by human neutrophils.
 |
MATERIALS AND METHODS |
Reagents.
Human recombinant interleukin-1
(IL-1
)
(specific activity, 3.4 × 104 U by
lymphocyte-activating assay; >99% purity), recombinant tumor necrosis
factor alpha (rTNF-
) (specific activity, 6 × 107
U/mg; >99% purity), and recombinant gamma interferon (rIFN-
) (specific activity, 2 × 107 U/mg; >99% purity) were
produced by Genentech Inc. (South San Francisco, Calif.) and kindly
provided by G. R. Adolf (Ernst Boehringer Ingelheim Institut,
Vienna, Austria). Human recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) was kindly provided by H. Aschauer
(Sandoz Forschungsinstitut, Vienna, Austria). The preparation contained
a specific activity of 6.2 × 107 U/mg when assayed
for colony formation by a chronic myeloid leukemia cell line. Murine
monoclonal antibody (MAb) immunoglobulin G (IgG) to human heat-labile
enterotoxin, TNF-
, and IFN-
were provided by G. R. Adolf,
and MAb (IgG) to IL-1
was obtained from Haem Pty. Ltd., Camberwell,
Victoria, Australia. These products contained <0.01 ng of
endotoxin/ml, as determined by Limulus amoebocyte lysate assay.
RPMI 1640 medium, medium 199, and Hanks balanced salt solution
(Cytosystems, Castle Hill, Australia), Percoll (Pharmacia LKB Biotechnology, Uppsala, Sweden), and [3H]hypoxanthine
(Amersham Corp., Arlington Heights, Ill.) were purchased. Trypan blue,
D-glucose,
N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES
buffer), and fluorescein isothiocyanate (FITC) were purchased from
Sigma Chemical Co., St. Louis, Mo. All reagents were prepared in
pyrogen-free distilled water according to the manufacturers'
instructions. Percoll (75%; d = 1.126) was prepared in
10× phosphate-buffered saline (PBS). The media, sera, buffers, and
cytokines were tested regularly for endotoxin contamination by
Limulus amoebocyte lysate assay.
Sera.
Immune plasma or sera were obtained from 30 adults who
were long-term residents in malaria-endemic areas in the Solomon
Islands and Papua New Guinea. These samples, referred to as immune sera (IS), contained high titers of anti-MSA-2 (merozoite surface antigen-2) antibody as detected by enzyme-linked immunosorbent assay compared to
sera obtained from healthy individuals who had not been to a
malaria-endemic area (normal sera [NS]). Sera from five adults that
contained high MSA-2 antibody levels were pooled and used in this
study. Both IS and NS were heated at 56°C for 30 min to inactivate complement.
Merozoites.
Synchronized P. falciparum (3D7 and
FC27 strains) in vitro cultures were maintained in fresh human RBC
(blood group O+; RBC with less than 1 week of storage at
4°C) in RPMI 1640 medium supplemented with 10% heat-inactivated
human group AB serum, 0.25% D-glucose, and 0.85% TES
buffer as described previously (17, 18). The cultures were
maintained in 60-ml volumes in culture flasks (175-cm2;
Nunc Co., Roskilde, Denmark) with daily culture changes and gassing
(1% O2 and 5% CO2 in N2).
Giemsa-stained smears were prepared to detect mature schizont counts.
Spontaneously released merozoites were collected from the cultures
containing 6 to 15% parasitized RBC with over 80% mature schizonts.
Merozoites were separated by layering 7 ml of cultures on 3 ml of
Percoll (75%) and centrifuging the tubes at 750 × g
for 5 min (19). The merozoite band (a dark band in the
liquid phase above Percoll) was suspended in PBS (9 ml) and subjected
to slow centrifugation (235 × g for 4 min) to remove
any contaminatory RBC. The supernatant containing merozoites was
aspirated into a syringe and filtered through two interconnected filters (Swinnex filters; 3- and 1.2-µm pore size in filter holders; Millipore Corp., Bedford, Mass.) to remove any contaminatory RBC or
infected RBC (21). The filtrate was centrifuged at
2,110 × g for 10 min, and the pellet was reconstituted
in a small volume of PBS. Comparisons were carried out of the
merozoites fixed in 1% formalin and washed several times, those killed
instantly by heating (at either 50 or 60°C for 1 min in a water bath
while being shaken gently), and those prepared from culture
supernatants without the use of Percoll gradient.
Preparation of FITC-conjugated merozoites.
Purified
merozoites (108/200 µl of PBS free of Ca2+
and Mg2+) were labeled with FITC (0.1 mg/ml) for 30 min at
37°C in the dark. Unbound FITC was removed by washing the merozoites
twice with PBS by centrifugation (2,113 × g for 10 min). The merozoites were dispensed into polystyrene tubes (9 by 76 mm)
at 5 × 106 in 100 µl of PBS/tube.
Preparation of neutrophils.
Neutrophils were prepared by the
rapid single-step technique (7). Freshly drawn peripheral
blood from healthy volunteers was layered onto Ficoll-Hypaque (density,
1.114) and centrifuged at 400 × g for 30 min. The
neutrophils, which resolved in the second leukocyte band, were
harvested and washed three times. These were >97% pure and >99%
viable as determined by the trypan blue exclusion method. The
neutrophils were suspended in PBS at 106/100 µl and mixed
with 100 µl of cytokines (0.10 to 1,000 U) or PBS (control) and
incubated at 37°C for 30 min.
Opsonization and interaction of merozoites with neutrophils.
Merozoites (5 × 105 in 100 µl) were mixed with 50 µl of sera (IS/NS/heat-inactivated NS [HNS]/HBSS diluted 1:3 with
RPMI 1640 medium), and the tubes were incubated at 37°C for 20 min.
They were then mixed with neutrophils (106 in 100 µl) and
incubated for various times (1, 5, 10, and 30 min) at 37°C in the
dark, with gentle mixing of the tubes after every 5 min. The tubes were
placed on ice following incubation, and flow cytometry analysis was
conducted immediately.
Flow cytometry analysis of phagocytosis.
Neutrophils that
had interacted with merozoites were analyzed on a fluorescence
activated cell scan (FACScan) with Lysis II software (Becton
Dickinson). Typically, 10,000 neutrophils were counted per tube. Debris
and nonadhered (free) merozoites were excluded by using forward scatter
and side scatter. The region for the neutrophil population was then
selected (Fig. 1A). In addition, to
ascertain that cells in the selected region were neutrophils, we also
stained the neutrophils by combined staining with CD16 FITC (Becton
Dickinson Immunocytometry Systems, San Jose, Calif.)-CD14
phycoerythrin (Dako Co., Glostrup, Denmark)-CD45 peridinin chlorophyll
protein. Neutrophils were identified as CD16 bright, CD45 bright, high
side scatter events. Monocytes were excluded as CD14 bright events.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Dot plot of neutrophils that have interacted with
P. falciparum merozoites (left) and neutrophils pretreated
with the cytokine TNF- that have interacted with merozoites
opsonized with IS (right). The neutrophil gate (R1) was defined as
described in Materials and Methods. SSC, side scatter; FSC, forward
scatter. (B) Histograms showing the fluorescence intensity of
FITC-conjugated merozoite association with neutrophils. Histogram A,
neutrophils incubated with merozoites in the absence of opsonin or
cytokines. Histogram B, cytokine (TNF- )-pretreated neutrophils when
allowed to interact with IS-opsonized merozoites, representing adhering
and ingested parasites. Histogram C, after trypan blue quenching of the
neutrophils from histogram B, representing only the ingested
merozoites. In every reading, the autofluorescence of neutrophils was
deducted from the median fluorescence intensity of histograms A, B, and
C.
|
|
Median fluorescence intensity (MFI) was recorded (Fig. 1B), and then 50 µl of trypan blue (0.4%) was added to the tubes to quench the
fluorescence of adhered (23, 30) merozoites. In preliminary
experiments, 0.1 to 4.0% trypan blue was used, and 0.4% was selected
as the optimum concentration which quenches the fluorescence from
adhered parasites without affecting that of ingested merozoites.
Histograms (Fig. 1B) were drawn based on MFI, and to remove the
autofluorescence of neutrophils from the neutrophils that had
interacted with FITC-conjugated merozoites, the value for neutrophils
alone was deducted.
Statistics.
The data are presented as means with standard
errors of the means (SEM) of triplicates and analyzed by the
t test for paired data.
 |
RESULTS |
Flow cytometry analysis of phagocytosis.
The flow cytometric
method enabled us to study at least 10,000 neutrophils per treatment
for the event of phagocytosis of P. falciparum merozoites.
As shown in Fig. 1A, there was an increase in the forward scatter due
to cytokine treatment of neutrophils and attachment of opsonized
merozoites to neutrophils. These differences were also reflected in the
histogram drawn on the basis of the median fluorescence intensity (Fig.
1B). The method allowed the differentiation of merozoites ingested
by neutrophils from those adhering to neutrophils (Fig. 1B). Trypan
blue (0.4%) addition effectively quenched the fluorescence of
merozoites adhering to neutrophils without affecting the fluorescence
of merozoites ingested by the neutrophils (Fig. 1B). This was also
confirmed by examining the samples treated or not treated with trypan
blue by microscopy under fluorescence (data not presented). While
heat-killed merozoites and the merozoites which were not subjected to
any treatment produced the same results, formalin-fixed merozoites were
not suitable for phagocytic studies (data not presented).
Comparison of the effects of NS, IS, HNS, and HIS.
Neutrophils
were allowed to react with merozoites which had been pretreated with
either IS, heat-inactivated IS (HIS), NS, or HNS. The neutrophils were
examined for ingestion and adherence of merozoites. The results showed
that IS markedly increased phagocytosis of merozoites compared to NS
(6-fold more) and HNS (12-fold more) (Fig.
2). When the data for individual samples
were assessed, 93% of the IS samples showed a greater degree of
phagocytosis-promoting activity than NS and 100% more than HNS. Heat
inactivation of IS did not significantly affect the IS-enhanced
phagocytosis of merozoites (data not presented).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of pooled IS, NS, and HNS (five samples from
different individuals) on phagocytosis of P. falciparum
merozoites by human neutrophils. Merozoites (5 × 105)
were incubated with 20% serum before being added to the neutrophils.
The means + SEM of four experiments are given. The statistics for
merozoite ingestion are as follows: IS versus NS or HNS, P < 0.001; NS versus HNS, P < 0.01. Open bars,
bound merozoites; solid bars, ingested merozoites.
|
|
Effects of cytokines.
The results shown in Fig.
3 indicate that the cytokines TNF-
,
GM-CSF, IL-1
, and IFN-
significantly enhanced phagocytosis of
merozoites by neutrophils in the presence of NS. The effect of these
cytokines was concentration dependent and is illustrated for IL-1
(Fig. 4). Treatment of the cytokine
preparation with cytokine-specific MAbs or heating at 80°C for 30 min
abolished the cytokine-induced increase in merozoite phagocytosis (data not shown).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of cytokine (100 U) pretreatment of human
neutrophils on the phagocytosis of P. falciparum merozoites
(5 × 105) in the presence of NS. The results are
presented as the means + SEM of three experiments, each
conducted with neutrophils from a different individual. The
statistics of merozoite ingestion are as follows: diluent versus
TNF- , IFN- , GM-CSF, and IL-1 , P < 0.025. Open
bars, bound merozoites; solid bars, ingested merozoites.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of various doses of IL-1 on
neutrophil-mediated phagocytosis of P. falciparum merozoites
in the presence of NS. The results are expressed as the means ± standard deviations of triplicates, which are representative of three
experiments. The diluent-treated neutrophils showed results similar to
those with IL-1 at 0.1 U/106 neutrophils. Neutrophils
pretreated with IL-1 at 100 and 1,000 U showed significantly higher
merozoite phagocytosis than diluent-treated cells (P < 0.01 and P < 0.001, respectively).
|
|
The results of the combined effects of the cytokine (TNF-
)
pretreatment of neutrophils and IS opsonization of merozoites are shown
in Fig. 5. Optimum merozoite ingestion
was seen in the presence of both TNF-
and IS. This effect was
significantly higher than the TNF-
-induced effects (P < 0.025) or IS effects (P < 0.01).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Combined effects of cytokine (100 U) pretreatment of
human neutrophils and opsonization of merozoites with pooled HIS and
HNS on the phagocytosis of P. falciparum merozoites by human
neutrophils. The results are presented as the means + SEM of three
experiments, each conducted with neutrophils from a different
individual. The statistics of merozoite ingestion are as follows:
TNF- + IS versus TNF- + HNS, P < 0.025. TNF- + IS versus HIS, P < 0.01.
Open bars, bound merozoites; solid bars, ingested merozoites.
|
|
Kinetics of merozoite phagocytosis.
The kinetics of merozoite
phagocytosis of neutrophils over a 30-min incubation was assessed. As
shown in Fig. 6, adhesion of parasites
occurred within minutes of contact with neutrophils. In the presence of
HNS, insignificant merozoite ingestion occurred at all time points.
Merozoites opsonized with NS were ingested at a higher rate than
those treated with HNS. In comparison, neutrophils pretreated with
TNF-
(in the presence of HNS) or neutrophils that had interacted
with merozoites opsonized with IS showed significantly higher ingestion
of merozoites than the neutrophils that had interacted with merozoites
exposed to NS or HNS.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 6.
Time-related effect of P. falciparum
merozoite ingestion by human neutrophils. Comparisons were made with
parasites opsonized with IS-NS-HNS without cytokine pretreatment of the
neutrophils or with parasites opsonized with HNS and allowed to
interact with TNF- (100 U/106 neutrophils). The results
are expressed as the means of triplicates which are representative of
two experiments.
|
|
 |
DISCUSSION |
Insight into the immune effector mechanisms against the merozoite
stage of P. falciparum is essential to develop strategies for vaccine development. In the present study we have argued that in
addition to the merozoite agglutination properties of antibody, other
immune responses against merozoites should also be elucidated. Our
results show that phagocytosis of P. falciparum merozoites can be influenced by many immune factors and that phagocytosis can be
efficiently measured by flow cytometry.
Although the immune factors which affect the P. falciparum
intraerythrocytic-stage elimination by the host have been described (16), the factors which affect merozoite phagocytosis remain to be appropriately studied. The studies carried out with monocyte phagocytosis of merozoites have described the effects of antibody, the
soluble factor(s) which is released during this interaction, and how
these factors cause degeneration of intraerythrocytic forms of P. falciparum (2, 26). The importance of complement, antimalarial antibody, and cytokines in the phagocytosis of merozoites by human neutrophils was clarified in the present study. The data showed that the cytokines IFN-
, TNF-
, IL-1
, and GM-CSF enhance merozoite phagocytosis by human neutrophils. These cytokines
are produced during malaria episodes, and their roles in relation to
immunity and the pathology of malaria have been discussed (6, 16,
28). This is consistent with previous findings which showed that
TNF-
and IFN-
enhance the neutrophil respiratory burst in
response to P. falciparum merozoites, as analyzed by
chemiluminescence (19). Results of studies of the kinetics
of phagocytosis showed that antibody and cytokines markedly increased
the rate of neutrophil phagocytosis of merozoites. The results also
showed that the maximum merozoite phagocytosis of neutrophils occurred
in the presence of both cytokines and opsonic antibody.
The flow cytometry assay described in this paper was done with purified
merozoites devoid of contamination with other parasitic stages, while
previous studies based on chemiluminescence (12, 19, 20, 24)
or morphology (13, 14, 19) have not addressed this aspect.
The flow cytometry method offers a simpler, rapid, more reproducible,
and less subjective method to study phagocytosis compared to previous
methods. An added advantage is the ability to distinguish adhering
merozoites from ingested merozoites by trypan blue quenching. In
contrast, a chemiluminescence response can be a result of nonadhering,
adhering, or ingested parasites. Compared to morphology, flow cytometry
allows the study of a larger number of neutrophils (10,000 in this
study) at a time. Previous morphology-based phagocytic studies have
described the fate of phagocytic cells or intraerythrocytic parasitic
stages rather than the fate of the merozoite (2, 13, 14,
19). It is difficult to quantitate how many merozoites have been
ingested; therefore, the studies have focused on how many phagocytes
are involved in phagocytosis of merozoites (19), while some
others addressed the fate of intraerythrocytic stages of P. falciparum during phagocytosis of merozoites (2, 13, 14,
26). In contrast, the present study provides a method to
follow the fate of the merozoites, and the extent of merozoite
adherence or ingestion.
This work not only illustrates the importance of immune serum
(containing high titers of MSA-2) in promoting merozoite phagocytosis but also shows a role for agonist cytokines. The action of both of
these factors is more likely to ensure removal of the merozoites than
either of them alone. The data parallel previous findings with the
intraerythrocytic asexual stage of these parasites, where phagocytosis
and killing of the organism were optimal when both antibody and
cytokines were present (16, 17). While aspects of the
relationship between opsonic antibody types and cytokine-induced heavy-chain gene switching remain speculative, it is evident that certain cytokine patterns give rise to opsonic antibodies and others
give rise to nonopsonic antibodies (15). Thus, in the context of the present findings with merozoites and previous reports on
intraerythrocytic asexual blood stages, a delicate balance seems to be
required between the type of cytokine pattern and the type of IgG
subclass response induced by parasite antigens. Based on the results of
this study and those of previous studies of P. falciparum intraerythrocytic stages (17, 18), this may best fit the type 1 cytokine pattern (Th1).
 |
ACKNOWLEDGMENTS |
We thank Greg Hodge, Department of Haematology, Women's
and Children's Hospital, Adelaide, Australia, for his help with the FACScan. Our thanks also extend to Christine Rzepczyk
(Queensland Institute of Medical Research, Herston, Brisbane,
Australia) for providing malaria immune sera. We are grateful to the
South Australian Branch of the Red Cross Blood Transfusion Centre for
providing blood and plasma packs for parasite cultures.
This work was supported by the UNDP/World Bank/WHO Special Program for
Research and Training in Tropical Diseases and a University of Adelaide
Research Grant.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunopathology, Women's and Children's Hospital, North Adelaide,
South Australia 5006, Australia. Phone: 61-8-82046637 or 61-8-82047216. Fax: 61-8-8204637031. E-mail:
lkumarat{at}medicine.adelaide.edu.au.
 |
REFERENCES |
| 1.
|
Bhatia, A., and A. Vernes.
1992.
Antigen diversity amongst ten geographic isolates of Plasmodium falciparum defined by inhibition assay.
Indian J. Malariol.
29:23-28[Medline].
|
| 2.
|
Bouharoun-tayoun, H.,
C. Oeuvray,
F. Lunel, and P. Druilhe.
1995.
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.
J. Exp. Med.
182:409-418[Abstract/Free Full Text].
|
| 3.
|
Cheung, A.,
J. Leban,
A. R. Shaw,
B. Merkli,
J. Stocker,
C. Chizzolini,
C. Sander, and L. H. Perrin.
1986.
Immunization with synthetic peptides of Plasmodium falciparum surface antigen induces antimerozoite antibodies.
Proc. Natl. Acad. Sci. USA
83:8328-8332[Abstract/Free Full Text].
|
| 4.
|
Cohen, S.
1979.
Immunity to malaria.
Proc. R. Soc. Lond. Biol. Sci.
15:203-245.
|
| 5.
|
Colman, J. P., and J. B. Jenson.
1988.
Affinity-purified antibodies to ring-infected erythrocyte surface antigen do not correlate with merozoite invasion inhibition in Plasmodium falciparum.
Infect. Immun.
56:457-461[Abstract/Free Full Text].
|
| 6.
|
Ferrante, A.,
L. M. Kumaratilake, and D. A. Rathjen.
1994.
The role of cytokine-activated phagocytic cells in immunity to malaria, p. 47-95.
In
M. F. Good, and F. J. Saul (ed.), Molecular immunological considerations in malaria vaccine development. CRC Press, Boca Raton, Fla.
|
| 7.
|
Ferrante, A., and Y. H. Thong.
1982.
Separation of mononuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.
J. Immunol. Methods
48:81-85[CrossRef][Medline].
|
| 8.
|
Franzen, L.,
B. Wahlin,
M. Wahlgren,
L. Aslund,
P. Perlmann,
H. Wigzell, and U. Petterson.
1989.
Enhancement of inhibition of Plasmodium falciparum erythrocyte reinvasion in vitro by antibodies to an asparagine rich protein.
Mol. Biochem. Parasitol.
32:201-211[CrossRef][Medline].
|
| 9.
|
Gerold, P.,
L. Schofield,
M. J. Blackman,
A. A. Holder, and R. T. Schwarz.
1996.
Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum.
Mol. Biochem. Parasitol.
75:131-143[CrossRef][Medline].
|
| 10.
|
Howard, R. J., and B. L. Pasloscke.
1993.
Target antigens for asexual malaria vaccine development.
Parasitol. Today
10:369-372.
|
| 11.
|
Jones, T. R., and S. L. Hoffman.
1994.
Malaria vaccine development.
Clin. Microbiol. Rev.
7:303-310[Abstract/Free Full Text].
|
| 12.
|
Kharazmi, A.,
S. Jepsen, and B. J. Andersen.
1987.
Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum.
Scand. J. Immunol.
25:335-341[CrossRef][Medline].
|
| 13.
|
Khusmith, S.,
P. Druilhe, and M. Gentilini.
1982.
Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals.
Infect. Immun.
35:874-879[Abstract/Free Full Text].
|
| 14.
|
Khusmith, S., and P. Druilhe.
1983.
Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes.
Parasite Immunol.
5:357-368[Medline].
|
| 15.
|
Kumaratilake, L. M., and A. Ferrante.
1993.
Unravelling the cytokine network in malaria.
Parasitol. Today
9:56-57.
|
| 16.
|
Kumaratilake, L. M., and A. Ferrante.
1994.
T cell cytokines in malaria: their role in the regulation of neutrophil- and macrophage-mediated killing of Plasmodium falciparum asexual blood forms.
Res. Immunol.
145:423-429[CrossRef][Medline].
|
| 17.
|
Kumaratilake, L. M.,
A. Ferrante, and C. M. Rzepczyk.
1990.
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.
Infect. Immun.
58:788-793[Abstract/Free Full Text].
|
| 18.
|
Kumaratilake, L. M.,
A. Ferrante, and C. M. Rzepczyk.
1991.
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and interferon- : comparisons with tumor necrosis factor effects.
J. Immunol.
146:762-767[Abstract].
|
| 19.
|
Kumaratilake, L. M.,
A. Ferrante,
T. Jaeger, and C. M. Rzepczyk.
1992.
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites.
Infect. Immun.
60:3731-3738[Abstract/Free Full Text].
|
| 20.
|
Lunel, F.,
L. B. Descamps, and P. Druilhe.
1990.
Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites.
Acta Trop.
47:61-68[CrossRef][Medline].
|
| 21.
|
Mrema, J. E. K.,
S. G. Langreth,
R. C. Jost,
K. H. Riekmann, and H. G. Heidrich.
1982.
Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves.
Exp. Parasitol.
54:285-295[CrossRef][Medline].
|
| 22.
|
Reeder, J., and G. V. Brown.
1996.
Antigenic variation and immune evasion in Plasmodium falciparum malaria.
Immunol. Cell Biol.
74:546-554[Medline].
|
| 23.
|
Sahlin, S.,
J. Hed, and I. Rundquist.
1983.
Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay.
J. Immunol. Methods
60:115-124[CrossRef][Medline].
|
| 24.
|
Salmon, D.,
J. L. Vilde,
B. Andrieu,
R. Simonovic, and J. Lebras.
1986.
Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum.
Infect. Immun.
51:801-806[Abstract/Free Full Text].
|
| 25.
|
Schofield, L.,
S. Novakovic,
P. Gerold,
R. T. Schwarz,
M. J. McConville, and S. D. Tachado.
1996.
Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction.
J. Immunol.
156:1886-1896[Abstract].
|
| 26.
|
Shi, Y. P.,
V. Udhayakumar,
A. J. Oloo,
B. L. Nahlen, and A. A. Lal.
1999.
Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites.
Am. J. Trop. Med. Hyg.
60:135-141[Abstract].
|
| 27.
|
Sjoberg, K.,
Z. Hosein,
B. Wahlin,
J. Carlsson,
M. Wahlgren,
M. Troy-Blomerg,
K. Berzins, and P. Perlman.
1991.
Plasmodium falciparum: an invasion inhibitory human monoclonal antibody is directed against a malarial glycolipid antigen.
Exp. Parasitol.
73:317-325[CrossRef][Medline].
|
| 28.
|
Stevenson, M. M.,
M. Nowotarski, and G. Yap.
1990.
Cytokines and malaria.
Clin. Investig. Med.
13:353-359[Medline].
|
| 29.
|
Sun, T., and C. Chakrabarti.
1985.
Schizonts, merozoites and phagocytosis in falciparum malaria.
Ann. Clin. Lab. Sci.
15:465-469[Abstract].
|
| 30.
|
Tan, A. M.,
A. Ferrante,
D. H. Goh,
D. M. Roberton, and A. W. Cripps.
1995.
Activation of the neutrophil bactericial activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin.
Paed. Res.
37:155-159.
|
| 31.
|
Wickramasinghe, S. N.,
R. E. Phillips,
S. Looareesuwan,
D. A. Warrell, and M. Hughes.
1987.
The bone marrow in human cerebral malaria: parasite sequestration within sinusoids.
Br. J. Haem.
66:295-306[Medline].
|
Clinical and Diagnostic Laboratory Immunology, January 2000, p. 9-13, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.